University of Basrah
  • Register
  • Login
  • العربیة

The Medical Journal of Basrah University

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 27, Issue 1
  3. Authors

Current Issue

By Issue

By Subject

Keyword Index

Author Index

Indexing Databases XML

About Journal

Aims and Scope

Editorial Board

Advisory Board

Editorial Staff

Facts and Figures

Publication Ethics

Indexing and Abstracting

Related Links

Peer Review Process

News

HUMAN RECOMBINANT ERYTHROPOIETIN IN THE TREATMENT OF ANEMIA OF PATIENTS WITH CHRONIC RENAL FAILURE

    Isam Hamo Mahmood Emadeldin Ibrahim Al-badrani Najlaa Saadi

The Medical Journal of Basrah University, 2009, Volume 27, Issue 1, Pages 7-10
10.33762/mjbu.2009.49013

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

ABSTRACT
Objective: To compare the effect of small doses of recombinant erythropoietin on anemia of patients with chronic
kidney disease who need dialysis and those are not on dialysis.
Design: Case-comparative study.
Setting: Nephrology Department in Al-Salaam Teaching Hospital, Mosul.
Methods: Eighty patients having chronic kidney disease (40 patients needed dialysis and 40 patients needed no
dialysis) participated in the study. Epoetin alfa given s.c. in a dose of 4000 IU, 2 times weekly. Hemoglobin was
measured before drug administration and every 2 weeks and at the end of the trial period (3 months).
Result: A significant increase of hemoglobin level had been obtained after treatment with erythropoietin in both
groups. Comparison between hemoglobin elevation of both groups ( 3.0 g/l for patients without dialysis and 2.9 g/l for
patients with dialysis) revealed a non significant difference (P>0.5).
Conclusion: the present study demonstrated that the administration of epoetin alfa, s.c. in a dose of 4000 IU twice
weekly is effective in the elevation of hemoglobin levels in patients with chronic kidney disease. The effect is
comparable in patients who need dialysis and in patients who need no dialysis, also the effect is similar in both sexes.
Keywords:
  • PDF
  • XML
(2009). HUMAN RECOMBINANT ERYTHROPOIETIN IN THE TREATMENT OF ANEMIA OF PATIENTS WITH CHRONIC RENAL FAILURE. The Medical Journal of Basrah University, 27(1), 7-10. doi: 10.33762/mjbu.2009.49013
Isam Hamo Mahmood; Emadeldin Ibrahim Al-badrani; Najlaa Saadi. "HUMAN RECOMBINANT ERYTHROPOIETIN IN THE TREATMENT OF ANEMIA OF PATIENTS WITH CHRONIC RENAL FAILURE". The Medical Journal of Basrah University, 27, 1, 2009, 7-10. doi: 10.33762/mjbu.2009.49013
(2009). 'HUMAN RECOMBINANT ERYTHROPOIETIN IN THE TREATMENT OF ANEMIA OF PATIENTS WITH CHRONIC RENAL FAILURE', The Medical Journal of Basrah University, 27(1), pp. 7-10. doi: 10.33762/mjbu.2009.49013
HUMAN RECOMBINANT ERYTHROPOIETIN IN THE TREATMENT OF ANEMIA OF PATIENTS WITH CHRONIC RENAL FAILURE. The Medical Journal of Basrah University, 2009; 27(1): 7-10. doi: 10.33762/mjbu.2009.49013
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 394
  • PDF Download: 323
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

 
This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus